SEARCH

SEARCH BY CITATION

REFERENCES

  • 1
    Ravelli A, Martini A. Macrophage activation syndrome. In: LehmanTH, CimazR, editors. Pediatric rheumatology. Amsterdam: Elsevier; 2008. p. 5563.
  • 2
    Prieur AM, Stephan JL. Macrophage activation syndrome in children with joint diseases. Rev Rhum Engl Ed 1994; 61: 3858.
  • 3
    Grom AA, Passo M. Macrophage activation syndrome in systemic juvenile rheumatoid arthritis. J Pediatr 1996; 129: 6302.
  • 4
    Sawhney S, Woo P, Murray KJ. Macrophage activation syndrome: a potentially fatal complication of rheumatic disorders. Arch Dis Child 2001; 85: 4216.
  • 5
    Athreya BH. Is macrophage activation syndrome a new entity? Clin Exp Rheumatol 2002; 20: 1213.
  • 6
    Ramanan AV, Schneider R. Macrophage activation syndrome—what's in a name! J Rheumatol 2003; 30: 25136.
  • 7
    Stephan JL, Kone-Paut I, Galanbrun C, Mouy R, Bader-Meunier B, Prieur AM. Reactive haemophagocytic syndrome in children with inflammatory disorders: a retrospective study of 24 patients. Rheumatology (Oxford) 2001; 40: 128592.
  • 8
    Ravelli A, Viola S, De Benedetti F, Magni-Manzoni S, Tzialla C, Martini A. Dramatic efficacy of cyclosporine A in macrophage activation syndrome [letter]. Clin Exp Rheumatol 2000; 19: 108.
  • 9
    Lambotte O, Khellaf M, Harmouche H, Bader-Meunier B, Manceron V, Goujard C, et al. Characteristic and long-term outcome of 15 episodes of systemic lupus erythematosus-associated hemophagocytic syndrome. Medicine (Baltimore) 2006; 85: 16982.
  • 10
    McCann LJ, Hasson N, Pilkington CA. Macrophage activation syndrome as an early presentation of lupus [letter]. J Rheumatol 2006; 33: 43840.
  • 11
    Avcin T, Tse S, Schneider R, Ngan B, Silverman E. Macrophage activation syndrome as the presenting manifestation of rheumatic disease in childhood. J Pediatr 2006; 148: 6836.
  • 12
    Pringe A, Trail L, Ruperto N, Buoncompagni A, Loy A, Breda L, et al. Macrophage activation syndrome in juvenile systemic lupus erythematosus: an under-recognized complication? Lupus 2007; 16: 58792.
  • 13
    Ravelli A, Magni-Manzoni S, Pistorio A, Besana C, Foti T, Ruperto N, et al. Preliminary diagnostic guidelines for macrophage activation syndrome complicating systemic juvenile idiopathic arthritis. J Pediatr 2005; 146: 598604.
  • 14
    Henter JI, Horne A, Arico M, Egeler RM, Filipovich AH, Imashuku S, et al. HLH-2004: diagnostic and therapeutic guidelines for hemophagocytic lymphohistiocytosis. Pediatr Blood Cancer 2007; 48: 12431.
  • 15
    Hochberg MC, for the Diagnostic and Therapeutic Criteria Committee of the American College of Rheumatology. Updating the American College of Rheumatology revised criteria for the classification of systemic lupus erythematosus [letter]. Arthritis Rheum 1997; 40: 1725.
  • 16
    Bloch DA, Moses LE, Michel BA. Statistical approaches to classification: methods for developing classification and other criteria rules. Arthritis Rheum 1990; 33: 113744.
  • 17
    Fries JF, Hochberg MC, Medsger TA Jr, Hunder GG, Bombardier C, and the American College of Rheumatology Diagnostic and Therapeutic Criteria Committee. Criteria for rheumatic disease: different types and different functions. Arthritis Rheum 1994; 37: 45462.
  • 18
    Bandeira M, Buratti S, Bartoli M, Gasparini C, Breda L, Pistorio A, et al. Relationship between damage accrual, disease flares and cumulative drug therapies in juvenile-onset systemic lupus erythematosus. Lupus 2006; 15: 51520.
  • 19
    Ravelli A, Duarte-Salazar C, Buratti S, Reiff A, Bernstein B, Maldonado-Velazquez MR, et al. Assessment of damage in juvenile-onset systemic lupus erythematosus: a multicenter cohort study. Arthritis Rheum 2003; 49: 5017.
  • 20
    Glas AS, Lijmer JG, Prins MH, Bonsel GJ, Bossuyt PM. The diagnostic odds ratio: a single indicator of test performance. J Clin Epidemiol 2003; 56: 112935.
  • 21
    Fukaya S, Yasuda S, Hashimoto T, Oku K, Kataoka H, Horita T, et al. Clinical features of haemophagocytic syndrome in patients with systemic autoimmune diseases: analysis of 30 cases. Rheumatology (Oxford) 2008; 47: 168691.
  • 22
    Morales PM, Jimenez BF, Yanes P, Rios D, Godinez R. Bone marrow (BM) with reactive histiocytosis (RH), hemophagocytosis and storage histiocytes (SH) in systemic lupus erythematosus [abstract]. Arthritis Rheum 1992; 35 Suppl: S239.
  • 23
    Tsuji T, Ohno S, Ishigatsubo Y. Liver manifestations in systemic lupus erythematosus: high incidence of hemophagocytic syndrome. J Rheumatol 2002; 29: 15767.
  • 24
    Janka GE. Familial hemophagocytic lymphohistiocytosis. Eur J Pediatr 1983; 140: 22130.
  • 25
    Gagnaire MH, Galambrun C, Stephan JL. Hemophagocytic syndrome: a misleading complication of visceral leishmaniasis in children—a series of 12 cases. Pediatrics 2000; 106: e58.
  • 26
    Tunc B, Ayata A. Hemophagocytic syndrome: a rare life-threatening complication of visceral leishmaniasis in a young boy. Pediatr Hematol Oncol 2001; 18: 5316.
  • 27
    Dhote R, Simon J, Papo T, Detournay B, Sailler L, Andre MH, et al. Reactive hemophagocytic syndrome in adult systemic disease: report of twenty-six cases and literature review. Arthritis Rheum 2003; 49: 6339.
  • 28
    Gaitonde S, Samols D, Kushner I. C-reactive protein and systemic lupus erythematosus. Arthritis Rheum 2008; 59: 181420.
  • 29
    Bleesing J, Prada A, Siegel DM, Villanueva J, Olson J, Ilowite NT, et al. The diagnostic significance of soluble CD163 and soluble interleukin-2 receptor α-chain in macrophage activation syndrome and untreated new-onset systemic juvenile idiopathic arthritis. Arthritis Rheum 2007; 56: 96571.
  • 30
    Mouy R, Stephan JL, Pillet P, Haddad E, Hubert P, Prieur AM. Efficacy of cyclosporine A in the treatment of macrophage activation syndrome in juvenile arthritis: report of five cases. J Pediatr 1996; 129: 7504.
  • 31
    Ravelli A, De Benedetti F, Viola S, Martini A. Macrophage activation syndrome in systemic juvenile rheumatoid arthritis successfully treated with cyclosporine. J Pediatr 1996; 128: 2758.
  • 32
    Ravelli A, Viola S, De Benedetti F, Magni-Manzoni S, Tzialla C, Martini A. Dramatic efficacy of cyclosporine A in macrophage activation syndrome [letter]. Clin Exp Rheumatol 2000; 19: 108.
  • 33
    Ideguchi H, Ohno S, Takase K, Hattori H, Kirino Y, Takeno M, et al. Successful treatment of refractory lupus-associated haemophagocytic lymphohistiocytosis with infliximab. Rheumatology (Oxford) 2007; 46: 16212.
  • 34
    Petty RE, Laxer RM. Systemic lupus erythematosus. In: CassidyJT, PettyRE, LaxerRM, LindsleyCB, editors. Textbook of pediatric rheumatology. Philadelphia: Elsevier; 2005. p. 342406.